-
Stimulus bill packs a windfall for FDA and COVID-19 drug developers — Roche nixes Tecentriq bladder cancer accelerated approval — AI uncovers Lilly's Olumiant as potential Alzheimer's treatment See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new pageDismiss Notice
MH's living kickbacks = LSA going away?
Discussion in 'Millennium Laboratories' started by anonymous, May 24, 2017 at 3:32 PM.